TELADOC HEALTH INC - NOTE 1.250% 6/0

CUSIP: 87918AAF2

Q4 2022 13F Holders as of 31 Dec 2022

SEC-reported market price (% of par)
76.87%
Principal change
-$100,867,900
Number of holders
65
Value change
-$73,724,755
Number of buys
28
Number of sells
24

Security key

87918AAF2

Report period

Q4 2022

Institutions

65

Top holders

10

Ownership snapshot

Top reported holders of 87918AAF2 - TELADOC HEALTH INC - NOTE 1.250% 6/0 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
65
Principal
$670,642,600
Rows available
65
Investor Option Weight % Change % SEC-reported value * Price (% of par) Principal Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
61
Q4 2022 holders
65
Holder diff
4
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .